Detalles de la búsqueda
1.
The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data.
Diabetes Obes Metab
; 23(7): 1604-1613, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33729661
2.
Impact of variable look-back periods on the incidence rates of chronic diseases using real world data.
Pharmacoepidemiol Drug Saf
; 29(9): 1086-1092, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32648308
3.
Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.
Diabetologia
; 60(9): 1691-1703, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28573394
4.
Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.
Diabetes Obes Metab
; 18(10): 990-8, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27282621
5.
Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR).
BMJ Open Diabetes Res Care
; 3(1): e000059, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25815205
6.
Metabolic effects of Basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: registry-based observational study in clinical practice.
Diabetes Ther
; 5(1): 243-54, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24828137
7.
Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register.
BMJ Open
; 3(4)2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23604419
8.
Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register.
BMJ Open
; 2(4)2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22798258
Resultados
1 -
8
de 8
1
Próxima >
>>